News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
253,186 Results
Type
Article (8909)
Company Profile (29)
Press Release (244248)
Multimedia
Podcasts (6)
Webinars (6)
Section
Business (89870)
Career Advice (560)
Deals (17410)
Drug Delivery (16)
Drug Development (27480)
Employer Resources (52)
FDA (5174)
Job Trends (5266)
News (139957)
Policy (10300)
Tag
2024 BioMidwest Digital (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
2026 Pharm Country Premier (1)
Academia (745)
Adcomms (11)
Allergies (25)
Alliances (17748)
ALS (25)
Alzheimer's disease (496)
Antibody-drug conjugate (ADC) (29)
Approvals (5226)
Artificial intelligence (69)
Autoimmune disease (1)
Automation (5)
Bankruptcy (126)
Best Places to Work (4463)
BIOSECURE Act (3)
Biosimilars (25)
Biotechnology (19)
Bladder cancer (15)
Brain cancer (8)
Breast cancer (70)
Cancer (738)
Cardiovascular disease (39)
Career advice (470)
Career pathing (10)
CAR-T (33)
Cell therapy (110)
Cervical cancer (8)
Clinical research (23075)
Collaboration (259)
Compensation (52)
Complete response letters (2)
COVID-19 (573)
CRISPR (12)
C-suite (99)
Cystic fibrosis (29)
Data (744)
Decentralized trials (1)
Denatured (3)
Depression (8)
Diabetes (91)
Diagnostics (2530)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (15)
Drug discovery (33)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (16)
Earnings (45978)
Editorial (2)
Employer branding (8)
Employer resources (47)
Events (36105)
Executive appointments (290)
FDA (5554)
Featured Employer (10)
Frontotemporal dementia (3)
Funding (203)
Gene editing (28)
Generative AI (7)
Gene therapy (74)
GLP-1 (135)
Government (1111)
Grass and pollen (1)
Guidances (27)
Healthcare (6588)
Huntington's disease (2)
IgA nephropathy (1)
Immunology and inflammation (15)
Indications (12)
Infectious disease (615)
Inflammatory bowel disease (43)
Influenza (18)
Intellectual property (33)
Interviews (87)
IPO (9655)
IRA (2)
Job creations (1005)
Job search strategy (423)
Kidney cancer (7)
Labor market (4)
Layoffs (78)
Leadership (4)
Legal (2203)
Liver cancer (23)
Lung cancer (123)
Lymphoma (48)
Machine learning (1)
Management (19)
Manufacturing (76)
MASH (9)
Medical device (5476)
Medtech (5476)
Mergers & acquisitions (8083)
Metabolic disorders (170)
Multiple sclerosis (25)
NASH (1)
Neurodegenerative disease (18)
Neuropsychiatric disorders (2)
Neuroscience (650)
NextGen: Class of 2025 (2304)
Non-profit (1329)
Northern California (759)
Now hiring (6)
Obesity (82)
Opinion (42)
Ovarian cancer (29)
Pain (18)
Pancreatic cancer (32)
Parkinson's disease (64)
Partnered (4)
Patents (73)
Patient recruitment (35)
Peanut (18)
People (23366)
Pharmaceutical (10)
Pharmacy benefit managers (1)
Phase I (6484)
Phase II (9972)
Phase III (8335)
Pipeline (515)
Policy (10)
Postmarket research (916)
Preclinical (2581)
Press Release (13)
Prostate cancer (29)
Psychedelics (3)
Radiopharmaceuticals (114)
Rare diseases (94)
Real estate (1925)
Recruiting (19)
Regulatory (7623)
Reports (12)
Research institute (744)
Resumes & cover letters (78)
RSV (13)
Schizophrenia (26)
Series A (31)
Series B (24)
Service/supplier (1)
Sickle cell disease (19)
Southern California (788)
Spinal muscular atrophy (30)
Sponsored (7)
Startups (1171)
State (1)
Stomach cancer (5)
Supply chain (16)
Tariffs (4)
The Weekly (3)
United States (7868)
Vaccines (156)
Venture capitalists (7)
Weight loss (30)
Women's health (5)
Worklife (5)
Date
Today (17)
Last 7 days (218)
Last 30 days (804)
Last 365 days (11605)
2025 (3298)
2024 (12923)
2023 (15606)
2022 (20144)
2021 (22345)
2020 (21824)
2019 (17703)
2018 (13579)
2017 (13571)
2016 (12164)
2015 (15283)
2014 (10889)
2013 (8535)
2012 (9432)
2011 (9568)
2010 (8411)
Location
Africa (261)
Alabama (8)
Arizona (51)
Arkansas (2)
Asia (16811)
Australia (2944)
California (1895)
Canada (646)
China (219)
Colorado (81)
Connecticut (81)
Delaware (47)
Europe (34612)
Florida (341)
Georgia (67)
Idaho (27)
Illinois (173)
India (9)
Indiana (131)
Iowa (1)
Japan (91)
Kansas (40)
Kentucky (8)
Louisiana (6)
Maine (44)
Maryland (260)
Massachusetts (1440)
Michigan (126)
Minnesota (134)
Mississippi (2)
Missouri (27)
Montana (13)
Nebraska (8)
Nevada (31)
New Hampshire (30)
New Jersey (717)
New Mexico (6)
New York (600)
North Carolina (422)
North Dakota (1)
Northern California (759)
Ohio (72)
Oklahoma (3)
Oregon (5)
Pennsylvania (480)
Puerto Rico (4)
Rhode Island (8)
South America (466)
South Carolina (11)
Southern California (788)
Tennessee (36)
Texas (308)
Utah (83)
Virginia (43)
Washington D.C. (12)
Washington State (182)
West Virginia (2)
Wisconsin (24)
253,186 Results for "lexington international llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genezen to Acquire uniQure’s Commercial Gene Therapy Manufacturing Operations in Lexington, MA
Genezen, a best-in-class gene therapy CDMO, announced an agreement to acquire uniQure’s commercial gene therapy operations in Lexington, MA, bringing a strategic manufacturing facility and a world-class team of employees to the company.
July 1, 2024
·
3 min read
Press Releases
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
April 22, 2025
·
2 min read
Press Releases
Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC
April 2, 2025
·
6 min read
Press Releases
Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share
April 3, 2025
·
4 min read
Press Releases
Innovative Lab Services LLC Acquires PL Consultants, LLC to Expand Scientific Capabilities and Service Offerings
January 15, 2025
·
2 min read
Press Releases
Kashiv BioSciences, LLC Obtains Marketing Authorization for Pegfilgrastim Injection from Health Canada
February 26, 2025
·
2 min read
Press Releases
H.C. Wainwright & Co., LLC Announces the Hiring of Elemer Piros and Brandon Folkes as Senior Research Analysts, and Expansion of Institutional Sales Team
April 22, 2025
·
2 min read
Press Releases
PANTHERx® Rare Selected by Upsher-Smith Laboratories, LLC as Specialty Pharmacy for VIGAFYDE™ (vigabatrin) Oral Solution
March 25, 2025
·
3 min read
Press Releases
Catheter Precision, Inc. Announces The Closing of its Acquisition of PeriKard, LLC
February 4, 2025
·
6 min read
Press Releases
ITF Therapeutics LLC Announces Opening of New U.S. Headquarters in Concord, Massachusetts
March 5, 2025
·
6 min read
1 of 25,319
Next
